Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-05-02

FDA Approved: BORTEZOMIB — Original Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved the original application for generic bortezomib by Zydus Pharmaceuticals USA Inc., enabling a generic version of the proteasome inhibitor for appro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bortezomib (bortezomib)

Snippet

ORIG AP for BORTEZOMIB (BORTEZOMIB)